Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
A startup hopes implanted insulin-producing cells will free diabetics from insulin injections.
A drugmaker is testing an alternative to diabetes injections, but many sizable hurdles remain.
A new system controls diabetics’ blood sugar by monitoring both insulin and glucagon.
Research on the Mexican genome could broaden the scope of personalized medicine.
Reprogrammed adult cells could be used to reconstruct diabetes in the laboratory.
Genetically engineered gut bacteria trigger insulin production in mice.
Scientists claim to have all but eliminated the risk of infection from the animal transplants.
Embryonic tissue could let xenotransplants evade the host’s immune system.
Some diabetics who received a stem-cell transplant do not need insulin injections years later.